删除或更新信息,请邮件至freekaoyan#163.com(#换成@)

Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of

本站小编 Free考研考试/2022-01-02

Wenyu Fu1,
Yujianan Chen1,
Kaidi Wang1,
Aubryanna Hettinghouse1,
Wenhuo Hu2,
Jing-Quan Wang3,
Zi-Ning Lei3,
Zhe-Sheng Chen3,
Kenneth A. Stapleford4,,,
Chuan-ju Liu1,5,,
1 Department of Orthopaedic Surgery, New York University Medical Center, 301 East 17 th Street, New York, NY 10003, USA;
2 Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA;
3 Department of Pharmaceutical Science, College of Pharmacy and Health Sciences, St. John's University, New York, NY 11439, USA;
4 Department of Microbiology, New York University School of Medicine, New York, NY 10016, USA;
5 Department of Cell Biology, New York University School of Medicine, New York, NY 10016, USA
Funds: This work was supported partly by NIH research grants R01AR062207, R01AR061484, R01NS103931, and R01AR076900 (CJ Liu).

Publish Date:2021-07-08




Abstract



PDF全文下载地址:

http://www.protein-cell.org/article/exportPdf?id=ccb004f4-f822-4649-a17c-3d4661739035&language=en
相关话题/Repurposing approved drugs